These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24499953)

  • 21. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
    Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
    J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis.
    Grint D; Peters L; Rockstroh JK; de Wit S; Mitsura VM; Knysz B; Pedersen C; Kirk O; Lundgren JD; Mocroft A;
    AIDS; 2014 Feb; 28(4):577-87. PubMed ID: 24468998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of insulin resistance in HIV/hepatitis C virus-coinfected patients.
    Eslam M; López-Cortés LF; Romero-Gomez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):553-8. PubMed ID: 21934619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China.
    Liu J; Chen X; Xie Q; Zhang W; Wei L; Shen T; Xu Q; Zhuang H; Gao F; Lu F
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):925-30. PubMed ID: 21114465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
    Daar ES; Lynn H; Donfield S; Gomperts E; O'Brien SJ; Hilgartner MW; Hoots WK; Chernoff D; Arkin S; Wong WY; Winkler CA;
    J Infect Dis; 2001 Feb; 183(4):589-95. PubMed ID: 11170984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in transaminases in hepatitis C virus- and HIV-coinfected patients after highly active antiretroviral therapy: differences between complete and partial virologic responders?
    Gavazzi G; Bouchard O; Leclercq P; Morel-Baccard C; Bosseray A; Dutertre N; Micoud M; Morand P
    AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1021-3. PubMed ID: 10933615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.
    Corma-Gómez A; Morano L; Téllez F; Rivero-Juárez A; Real LM; Alados JC; Ríos-Villegas MJ; Vera-Méndez FJ; Muñoz RP; Geijo P; Macías J; Pineda JA;
    AIDS; 2019 Jun; 33(7):1167-1174. PubMed ID: 30845068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life.
    Cacoub P; Rosenthal E; Halfon P; Sene D; Perronne C; Pol S
    J Viral Hepat; 2006 Oct; 13(10):678-82. PubMed ID: 16970599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.
    Peters L; Mocroft A; Soriano V; Rockstroh JK; Kirkby N; Reiss P; Katlama C; Zakharova N; Flisiak R; Lundgren JD;
    HIV Med; 2014 Nov; 15(10):615-20. PubMed ID: 24814468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study.
    Yeung MW; Young J; Moodie E; Rollet-Kurhajec KC; Schwartzman K; Greenaway C; Cooper C; Cox J; Gill J; Hull M; Walmsley S; Klein MB
    HIV Clin Trials; 2015; 16(3):100-10. PubMed ID: 25972048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy.
    Bower WA; Culver DH; Castor D; Wu Y; James VN; Zheng H; Hammer S; Kuhnert WL; Williams IT; Bell BP; Vlahov D; Dezzutti CS
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):293-7. PubMed ID: 16763522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C viral load, genotype 3 and interleukin-28B CC genotype predict mortality in HIV and hepatitis C-coinfected individuals.
    Clausen LN; Astvad K; Ladelund S; Larsen MV; Schønning K; Benfield T
    AIDS; 2012 Jul; 26(12):1509-16. PubMed ID: 22555162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.
    Bräu N; Salvatore M; Ríos-Bedoya CF; Fernández-Carbia A; Paronetto F; Rodríguez-Orengo JF; Rodríguez-Torres M
    J Hepatol; 2006 Jan; 44(1):47-55. PubMed ID: 16182404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving HCV cure rates in HIV-coinfected patients - a real-world perspective.
    Lakshmi S; Alcaide M; Palacio AM; Shaikhomer M; Alexander AL; Gill-Wiehl G; Pandey A; Patel K; Jayaweera D; Del Pilar Hernandez M
    Am J Manag Care; 2016 May; 22(6 Spec No.):SP198-204. PubMed ID: 27266949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus.
    Lai AR; Tashima KT; Taylor LE
    AIDS Patient Care STDS; 2006 Oct; 20(10):678-92. PubMed ID: 17052138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects.
    Zylberberg H; Chaix ML; Rabian C; Rouzioux C; Aulong B; Bréchot C; Viard JP; Pol S
    Clin Infect Dis; 1998 May; 26(5):1104-6. PubMed ID: 9597236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.